| Main purpose |
Broad gut health overview paired with personalized nutrition and supplement guidance. |
Gut microbiome profiling with its own reporting and interpretation framework. |
| Best for |
People who want actionable food and supplement recommendations that are easy to follow. |
People who want microbiome insights and are comfortable with the competitor’s reporting style. |
| Sample type |
Stool sample(s) collected at home. |
Stool sample(s) collected at home. |
| Analysis method |
Uses 16S DNA sequencing and Shotgun Metagenomics within its Gut Health Operating System. |
Typically DNA-based microbiome profiling (exact method details can vary by plan and study). |
| What it measures |
Your gut microbiome composition and related markers, interpreted into gut-health context. |
Gut microbiome composition and related markers, interpreted into its own reports. |
| Pathogens included? |
Unclear from the provided info; reports focus mainly on gut ecosystem and recommendations. |
Unclear from the provided info; pathogen coverage depends on the specific reporting scope. |
| Functional / microbiome balance insight |
Provided via an ecosystem/functional view and translated into recommendations. |
Provided via the competitor’s functional or balance interpretation (scope depends on their reporting). |
| Broad gut health overview |
Yes—positioned as a broad overview of gut health and your microbiome ecosystem. |
Often yes—positioned as gut microbiome insights with a structured overview. |
| Personalized recommendations |
Yes—personalized nutrition and probiotics/prebiotics suggestions based on your data. |
Yes—personalized recommendations based on the competitor’s interpretation approach. |
| Nutrition guidance included |
Yes—driven by 3-day food diaries mapped to stool results, including individual foods with daily dosage. |
May be included depending on plan; the level of detail can vary. |
| Actionability of results |
High—aims to turn findings into specific food and supplement actions you can implement. |
Moderate to high—actionability depends on how their report translates findings into next steps. |
| Easy-to-understand report |
Consumer-friendly, designed to be easy to understand. |
Varies—may be more detailed or report-style oriented depending on their format. |
| Consumer-friendly vs clinician-focused |
Consumer-focused, with interpretation aimed at everyday choices. |
Can be more clinician/report oriented depending on how results are presented. |
| Suitable for ongoing monitoring |
Yes—sequencing approach is positioned to allow longitudinal comparisons over time. |
Often yes—DNA-based methods can support repeat testing, depending on the test protocol. |
| Turnaround time |
Not provided here. |
Not provided here. |
| Price |
Not provided here. |
Not provided here. |
| Available in Europe / direct-to-consumer |
Yes—available in Europe and direct-to-consumer. |
Often available in Europe depending on current distribution; verify current service coverage. |
| Data privacy / EU friendliness |
Not provided here; EU friendliness would depend on their privacy practices and data handling. |
Not provided here; EU readiness depends on their privacy policies and data processing. |